Subacute sclerosing panencephalitis (SSPE) the story of a vanishing disease

Brain and Development

Volumn 34, Issue 9, 2012, Pages 705-711

  Gadoth, Natan ^a,b  

^a Department of Obstetrics and Gynecology   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Encephalitis; Epidemiology; Immunization; Measles; Myoclonus; Slow virus

Indexed keywords

CLONAZEPAM; HUMORAL THYMUS FACTOR; MEASLES ANTIBODY; METHISOPRINOL; METHYLPHENIDATE;

AGNOSIA; ANTIBODY TITER; ASPIRATION PNEUMONIA; COMMON COLD; CONSCIOUSNESS DISORDER; DETERIORATION; DEVELOPMENTAL COORDINATION DISORDER; DIAGNOSTIC ERROR; EEG ABNORMALITY; ERADICATION THERAPY; FALLING; FEVER; GLASGOW COMA SCALE; HUMAN; MEASLES VACCINATION; MINIMAL BRAIN DYSFUNCTION; MYOCLONUS; PATHOPHYSIOLOGY; SHORT SURVEY; SUBACUTE SCLEROSING PANENCEPHALITIS;

BRAIN; CHILD; ELECTROENCEPHALOGRAPHY; FEMALE; HISTORY, 20TH CENTURY; HUMANS; MALE; MASS VACCINATION; NEUROIMAGING; RETROSPECTIVE STUDIES; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 84865612300     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.12.008     Document Type: Short Survey

References (36)

1. CDC, Morbidly and Mortality (MMWR) Weekly Report. Notes from the field Measles Outbreak - Indiana, June-July 2011. MMWR, September 2, 2011; 60: 1169.
2. Stein-Zamir C., Shoob H., Abramson N., Zentner G. Who are the children at risk? Lessons learned from measles outbreaks. Epidemiol Infect 2011, 25:1-11.
3. Gutierrez J., Issacson R.S., Koppel, BS Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol 2010, 52:901-907.
4. Manning L., Laman M., Edoni H., Mueller I., Karunajeewa H.A. Subacute sclerosing panencephalitis in Papua New Guinean children: the cost of continuing inadequate measles vaccine coverage. Public Library Sci (PLoS) Neglected Tropical Diseuses 2011, 5:e932. 1-8.
5. Dawson J.R. Cellular inclusions in cerebral lesions of lethargic encephalitis. Am J Pathol 1933, 9:7-15.
6. Dawson J.R. Cellular inclusions in cerebral lesions of epidemic encephalitis. Arch Neurol Psychiatr 1934, 31:685-700.
7. Pette H., Doring G. über einheimische panencephalomyelitis vom charaker der encephalitis japonica. Deuts Zeit Nerven 1939, 149:7-44.
8. Van Bogaert L. Une leocoencephalite sclerosante subaigue. J Neurol Neurosurg Psychiatr 1945, 8:101-120.
9. Poser C.M., Radermecker J. Subacute Sclerosing leucoencephalitis. J Pediatr 1957, 50:408-425.
10. Greenfield J.G. Encephalitis and encephalomyelitis in England and Wales during the last decade. Brain 1950, 73:141-166.
11. Boutellie M., Fontaine C., Vedrenne C.L. Sur un cas d'encephalite subaigue a inclusions. Etude Anatomoclinique et ultrastructurale. Rev Neurol 1965, 113:454-458.
12. Connolly J.H., Allen I.V., Hurwitz L.I., Millar J.H. Measles virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1967, 1(7489):542-544.
13. Kuroda Y., Matsui M. Progressive rubella panencephalitis. Nihon Rinsho 1997, 55:922-925. Article in Japanese.
14. Gilden D.H. Slow virus diseases of the CNS. 1. Subacute sclerosing panencephalitis, progressive rubella panencephalitis, and progressive multifocal leukoencephalopathy. Postgrad Med 1983, 73. 99-101, 104-8.
15. Prashanth L.K., Taly A.B., Ravi V., Arunodaya G.R. Adult onset subacute sclerosing panencephalitis: clinical profile of 39 patients from a tertiary care centre. J Neurol Neurosurg Psychiatr 2006, 77:630-633.
16. PeBenito R., Naqvi S.H., Arca M.M., Schubert R. Fulminating subacute sclerosing panencephalitis: case report and literature review. Clin Pediatr 1997, 36:149-154.
17. Kissani N., Ouazzani R., Belaidi H., Ouahabi H., Chkili T. Crises épileptiques et épilepsie dans le cadre d'une panencéphalite sclérosante subaiguë (à propos de 30 cas). Neurophysiol Clin 2001, 31:398-405.
18. Demir E., Ozcelik A., Arhan E., Serdaroglu A., Gucuyener K. Atypical presentations of subacute sclerosing panencephalitis in two neurologically handicapped cases. Neuropediatrics 2009, 40:195-198.
19. Cherian A., Sreedharan S., Raghavendra S., Nayak D., Radhakrishnan A. Periodic lateralized epileptiform discharges in fulminant form of SSPE. Can J Neurol Sci 2009, 36:524-526.
20. Fabian V.A., Yee Lee H., Keith-Rokosh J.L., de Souza J.L., Stewart-Wynne E. A 22-year-old Australian woman with atypical subacute sclerosing panencephalitis diagnosed at postmortem. J Clin Neurosci 2010, 17:1192-1194.
21. Aydin K., Okur O., Tatli B., Sarwar S.G., Ozturk C., Dilber C. Reduced gray matter volume in the frontotemporal cortex of patients with early subacute sclerosing panencephalitis. AJNR 2009, 30:271-275.
22. Praveen-kumar S., Sinha S., Taly A.B., Jayasree S., Ravi V., Vijayan J. At al. Electroencephalographic and imaging profile in a subacute sclerosing panencephalitis (SSPE) cohort: a correlative study. Clin Neurophysiol 2007, 118:1947-1954.
23. Tuxhorn I.E. Familial subacute sclerosing panencephalitis in two siblings. Pediatr Neurol 2004, 31:291-294.
24. Griffin D.E., Ward B.J., Esolen L.M. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 1994, 170(Suppl. 1):S24-S31.
25. Handzel Z., Gadoth N., Idar D., Schlesinger M., Kahana E., Dagan R., et al. Cell mediated immunity and effect of " thymic humoral factor" in 15 patients with SSPE. Brain Dev 1983, 5:29-35.
26. Yentur S.P., Gürses C., Demirbilek V., Yilmaz G., Onal A.E., Yapici Z., et al. Alterations in cell-mediated immune response in subacute sclerosing panencephalitis. J Neuroimmunol 2005, 170:179-185.
27. Hara T., Yamashita S., Aiba H., Nihei K., Koide N., Good R.A., et al. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000, 6:121-126.
28. Nagano I., Nakamura S., Yoshioka M., Onodera J., Kogure K., Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 1994, 44:710-715.
29. Inoue T., Kira R., Nakao F., et al. Contribution of the interleukin 4 gene to Susceptibility to subacute sclerosing panencephalitis. Arch Neurol 2002, 59:822-827.
30. Okuno Y., Nakao T., Ishida N., Konno T., Mizutani H., Fukuyama Y., et al. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Int J Epidemiol 1989, 18:684-698.
31. Zilber N., Rannon L., Alter M., Kahana E. Measles, measles vaccination and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983, 33:1558-1564.
32. Soffer D., Rannon L., Alter M., Kahana E., Feldman S. Subacute sclerosing panencephalitis: an epidemiologic study in Israel. Amr J Epidemiol 1976, 103:67-74.
33. Gadoth N., Kott E., Levin S., Hahn T. The interferon system in subacute sclerosing panencephalitis and its response to Isoprinosine. Brain Dev 1989, 11:308-312.
34. Hara S., Kimura H., Hoshino Y., et al. Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay. Brain Dev 2003, 25:367-369.
35. Titomanlio L., Soyah N., Guerin V., et al. Rituximab in subacute sclerosing panencephalitis. Eur J Paediatr Neurol 2007, 11:43-45.
36. Panagariya A., Sureka R.K., Aurora A. Current developments in the management of subacute sclerosing panencephalitis. J Assoc Physicians India 1998, 46:218-220. patients during the period of 1966-1986.